|Immunobiology of mesenchymal stem cells|
S Ma, N Xie, W Li, B Yuan, Y Shi, Y Wang
Cell Death & Differentiation 21 (2), 216-225, 2014
|Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair|
Y Shi, G Hu, J Su, W Li, Q Chen, P Shou, C Xu, X Chen, Y Huang, Z Zhu, ...
Cell research 20 (5), 510-518, 2010
|Concise Review: Mesenchymal Stem Cells and Translational Medicine: Emerging Issues|
G Ren, X Chen, F Dong, W Li, X Ren, Y Zhang, Y Shi
Stem Cells Translational Medicine 1 (1), 51-58, 2012
|Mesenchymal stem cells: a double-edged sword in regulating immune responses|
W Li, G Ren, Y Huang, J Su, Y Han, J Li, X Chen, K Cao, Q Chen, P Shou, ...
Cell Death & Differentiation, 2012
|An osteopontin‐integrin interaction plays a critical role in directing adipogenesis and osteogenesis by mesenchymal stem cells|
Q Chen, P Shou, L Zhang, C Xu, C Zheng, Y Han, W Li, Y Huang, ...
Stem cells 32 (2), 327-337, 2014
|Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species|
J Su, X Chen, Y Huang, W Li, J Li, K Cao, G Cao, L Zhang, F Li, ...
Cell Death & Differentiation 21 (3), 388-396, 2014
|CD5 Binds to Interleukin-6 and Induces a Feed-Forward Loop with the Transcription Factor STAT3 in B Cells to Promote Cancer|
C Zhang, H Xin, W Zhang, PJ Yazaki, Z Zhang, KL Le, W Li, H Lee, ...
Immunity 44 (4), 913-923, 2016
|The interaction between mesenchymal stem cells and steroids during inflammation|
X Chen, Y Gan, W Li, J Su, Y Zhang, Y Huang, AI Roberts, Y Han, J Li, ...
Cell death & disease 5 (1), e1009-e1009, 2014
|p53 regulates mesenchymal stem cell-mediated tumor suppression in a tumor microenvironment through immune modulation|
Y Huang, P Yu, W Li, G Ren, AI Roberts, W Cao, X Zhang, J Su, X Chen, ...
Oncogene 33 (29), 3830-3838, 2014
|Histone deacetylase inhibitors prevent activation-induced cell death and promote anti-tumor immunity|
K Cao, G Wang, W Li, L Zhang, R Wang, Y Huang, L Du, J Jiang, C Wu, ...
Oncogene 34 (49), 5960-5970, 2015
|STAT3 in CD8+ T cells inhibits their tumor accumulation by downregulating CXCR3/CXCL10 axis|
C Yue, S Shen, J Deng, SJ Priceman, W Li, A Huang, H Yu
Cancer immunology research 3 (8), 864-870, 2015
|STAT3 activation-induced fatty acid oxidation in CD8+ T effector cells is critical for obesity-promoted breast tumor growth|
C Zhang, C Yue, A Herrmann, J Song, C Egelston, T Wang, Z Zhang, W Li, ...
Cell metabolism 31 (1), 148-161. e5, 2020
|CD8+ T‐cell immunosurveillance constrains lymphoid premetastatic myeloid cell accumulation|
W Zhang, C Zhang, W Li, J Deng, A Herrmann, SJ Priceman, W Liang, ...
European journal of immunology 45 (1), 71-81, 2015
|CTLA4 Promotes Tyk2-STAT3–Dependent B-cell Oncogenicity|
A Herrmann, C Lahtz, T Nagao, JY Song, WC Chan, H Lee, C Yue, T Look, ...
Cancer research 77 (18), 5118-5128, 2017
|Mechanism of Immunosuppression and Clinical Applications of Mesenchymal Stem Cells|
PS Shou, Y Huang, JJ Su, Q Chen, WZ Li, XL Tian, GW Xu, GW Ren, ...
Chinese Journal of Cell Biology, 01, 2009
|Sphingosine-1-phosphate receptor-1 promotes environment-mediated and acquired chemoresistance|
V Lifshitz, SJ Priceman, W Li, G Cherryholmes, H Lee, ...
Molecular cancer therapeutics 16 (11), 2516-2527, 2017
|Immunomodulatory properties of mesenchymal stem cells|
X HUANG, X HAN, Y HONG, J SU, X TIAN, Q CHEN, W LI, P SHOU, ...
Chinese Bulletin of Life Sciences, 05, 2009